Invivyd, Inc. (IVVD)
1.56
+0.03
(+1.96%)
USD |
NASDAQ |
Feb 13, 16:00
1.57
+0.01
(+0.64%)
After-Hours: 20:00
Invivyd EPS Diluted (Quarterly) : -0.0615 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Relmada Therapeutics, Inc. | -0.304 |
| Arcellx, Inc. | -0.9858 |
| MannKind Corp. | 0.0256 |
| ADMA Biologics, Inc. | 0.1489 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.47M |
| Revenue (Quarterly) | 13.13M |
| Total Expenses (Quarterly) | 23.60M |
| Enterprise Value | 281.38M |
| Gross Profit Margin (Quarterly) | 88.43% |
| Profit Margin (Quarterly) | -79.75% |
| Earnings Yield | -30.35% |
| Normalized Earnings Yield | -30.35 |